Drugs with directed molecules increase life expectancy by five years in breast cancer patients
Clinical studies show that new drugs that target malignant cells of HER2-positive breast cancer, such as Pertuzumab and Trastuzumab Emtansine (T-DM1), increase life expectancy in patients with advanced breast cancer.
Nov 5, 2015
0
19